

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 4.80711032 |
| 2 | viral transcription (GO:0019083) | 4.26009837 |
| 3 | ribosomal small subunit assembly (GO:0000028) | 4.22798307 |
| 4 | autophagic vacuole fusion (GO:0000046) | 4.18418776 |
| 5 | ribosomal small subunit biogenesis (GO:0042274) | 4.15923179 |
| 6 | translational termination (GO:0006415) | 4.08350671 |
| 7 | SRP-dependent cotranslational protein targeting to membrane (GO:0006614) | 4.06800337 |
| 8 | protein targeting to ER (GO:0045047) | 3.99644564 |
| 9 | cotranslational protein targeting to membrane (GO:0006613) | 3.96597561 |
| 10 | deoxyribonucleoside monophosphate metabolic process (GO:0009162) | 3.96361033 |
| 11 | protein localization to endoplasmic reticulum (GO:0070972) | 3.88977650 |
| 12 | establishment of protein localization to endoplasmic reticulum (GO:0072599) | 3.86200931 |
| 13 | pyrimidine deoxyribonucleotide catabolic process (GO:0009223) | 3.53329418 |
| 14 | organelle membrane fusion (GO:0090174) | 3.51615162 |
| 15 | COPI coating of Golgi vesicle (GO:0048205) | 3.49152000 |
| 16 | Golgi transport vesicle coating (GO:0048200) | 3.49152000 |
| 17 | mitochondrial calcium ion transport (GO:0006851) | 3.47750639 |
| 18 | pyrimidine deoxyribonucleotide metabolic process (GO:0009219) | 3.43203866 |
| 19 | maturation of SSU-rRNA (GO:0030490) | 3.36396084 |
| 20 | translational elongation (GO:0006414) | 3.35278712 |
| 21 | viral life cycle (GO:0019058) | 3.30208198 |
| 22 | G-protein coupled purinergic nucleotide receptor signaling pathway (GO:0035589) | 3.29459108 |
| 23 | ribosomal large subunit biogenesis (GO:0042273) | 3.28480586 |
| 24 | protein maturation by protein folding (GO:0022417) | 3.27891200 |
| 25 | positive regulation of natural killer cell differentiation (GO:0032825) | 3.20212742 |
| 26 | positive regulation of gamma-delta T cell activation (GO:0046645) | 3.19169845 |
| 27 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay (GO:0000184) | 3.12848909 |
| 28 | translational initiation (GO:0006413) | 3.03842638 |
| 29 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid metabolic process (GO:1902221) | 3.01066934 |
| 30 | L-phenylalanine metabolic process (GO:0006558) | 3.01066934 |
| 31 | deoxyribose phosphate biosynthetic process (GO:0046385) | 3.00023052 |
| 32 | 2-deoxyribonucleotide biosynthetic process (GO:0009265) | 3.00023052 |
| 33 | pyrimidine nucleotide catabolic process (GO:0006244) | 2.97018212 |
| 34 | cellular protein complex disassembly (GO:0043624) | 2.96414410 |
| 35 | positive regulation of cellular amide metabolic process (GO:0034250) | 2.95173552 |
| 36 | imidazole-containing compound metabolic process (GO:0052803) | 2.94501273 |
| 37 | protein retention in ER lumen (GO:0006621) | 2.94415147 |
| 38 | positive regulation of heat generation (GO:0031652) | 2.90060263 |
| 39 | maintenance of protein localization in endoplasmic reticulum (GO:0035437) | 2.80996749 |
| 40 | nucleotide salvage (GO:0043173) | 2.80653454 |
| 41 | xenobiotic catabolic process (GO:0042178) | 2.79261690 |
| 42 | hyaluronan catabolic process (GO:0030214) | 2.78656651 |
| 43 | T cell apoptotic process (GO:0070231) | 2.78424014 |
| 44 | antigen processing and presentation of endogenous peptide antigen via MHC class I (GO:0019885) | 2.77835257 |
| 45 | antigen processing and presentation of endogenous peptide antigen (GO:0002483) | 2.77835257 |
| 46 | NIK/NF-kappaB signaling (GO:0038061) | 2.75550521 |
| 47 | T-helper cell differentiation (GO:0042093) | 2.74124303 |
| 48 | CD4-positive, alpha-beta T cell differentiation involved in immune response (GO:0002294) | 2.74124303 |
| 49 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 2.73976316 |
| 50 | translation (GO:0006412) | 2.70579192 |
| 51 | superoxide anion generation (GO:0042554) | 2.68956064 |
| 52 | deoxyribonucleotide catabolic process (GO:0009264) | 2.68795995 |
| 53 | response to peptidoglycan (GO:0032494) | 2.68299131 |
| 54 | ribonucleoprotein complex biogenesis (GO:0022613) | 2.67372361 |
| 55 | protein targeting to membrane (GO:0006612) | 2.66593336 |
| 56 | negative regulation of release of cytochrome c from mitochondria (GO:0090201) | 2.66576995 |
| 57 | negative regulation of transcription elongation from RNA polymerase II promoter (GO:0034244) | 2.65828864 |
| 58 | macrophage activation involved in immune response (GO:0002281) | 2.65767107 |
| 59 | positive regulation by symbiont of host defense response (GO:0052509) | 2.65508259 |
| 60 | modulation by symbiont of host defense response (GO:0052031) | 2.65508259 |
| 61 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 2.65508259 |
| 62 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 2.65508259 |
| 63 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 2.65508259 |
| 64 | modulation by symbiont of host immune response (GO:0052553) | 2.65508259 |
| 65 | positive regulation of T cell mediated cytotoxicity (GO:0001916) | 2.65205558 |
| 66 | histone H3-K4 trimethylation (GO:0080182) | 2.64519412 |
| 67 | phosphatidylglycerol biosynthetic process (GO:0006655) | 2.64396861 |
| 68 | positive regulation of heterotypic cell-cell adhesion (GO:0034116) | 2.63682804 |
| 69 | pyrimidine-containing compound salvage (GO:0008655) | 2.61464651 |
| 70 | pyrimidine nucleoside salvage (GO:0043097) | 2.61464651 |
| 71 | deoxyribose phosphate catabolic process (GO:0046386) | 2.61008058 |
| 72 | microglial cell activation (GO:0001774) | 2.60456917 |
| 73 | lymphocyte apoptotic process (GO:0070227) | 2.57380084 |
| 74 | negative regulation of DNA-templated transcription, elongation (GO:0032785) | 2.55937020 |
| 75 | telomere maintenance via semi-conservative replication (GO:0032201) | 2.51712925 |
| 76 | polyketide metabolic process (GO:0030638) | 2.51622015 |
| 77 | doxorubicin metabolic process (GO:0044598) | 2.51622015 |
| 78 | daunorubicin metabolic process (GO:0044597) | 2.51622015 |
| 79 | deoxyribonucleoside triphosphate metabolic process (GO:0009200) | 2.51146871 |
| 80 | response to muramyl dipeptide (GO:0032495) | 2.49965095 |
| 81 | regulation of branching involved in salivary gland morphogenesis (GO:0060693) | 2.49939435 |
| 82 | formation of translation preinitiation complex (GO:0001731) | 2.49848441 |
| 83 | aerobic respiration (GO:0009060) | 2.49826847 |
| 84 | regulation of heat generation (GO:0031650) | 2.49732174 |
| 85 | protein complex disassembly (GO:0043241) | 2.48715894 |
| 86 | pyrimidine nucleoside monophosphate metabolic process (GO:0009129) | 2.48382596 |
| 87 | negative regulation of myeloid cell apoptotic process (GO:0033033) | 2.47998858 |
| 88 | detection of other organism (GO:0098543) | 2.47997379 |
| 89 | exocrine pancreas development (GO:0031017) | 2.45743745 |
| 90 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 2.44098262 |
| 91 | proteasome assembly (GO:0043248) | 2.43257109 |
| 92 | glycolipid catabolic process (GO:0019377) | 2.42754065 |
| 93 | glycosphingolipid catabolic process (GO:0046479) | 2.42062036 |
| 94 | detection of molecule of bacterial origin (GO:0032490) | 2.41347836 |
| 95 | positive regulation of interferon-alpha production (GO:0032727) | 2.41335701 |
| 96 | establishment of protein localization to mitochondrial membrane (GO:0090151) | 2.40365683 |
| 97 | negative regulation of lipid storage (GO:0010888) | 2.40314277 |
| 98 | regulation of fever generation (GO:0031620) | 2.38595036 |
| 99 | regulation of interferon-alpha production (GO:0032647) | 2.38591738 |
| 100 | deoxyribonucleotide biosynthetic process (GO:0009263) | 2.38440366 |
| 101 | definitive hemopoiesis (GO:0060216) | 2.37779346 |
| 102 | regulation of interferon-beta biosynthetic process (GO:0045357) | 2.37623328 |
| 103 | neutrophil activation involved in immune response (GO:0002283) | 2.37120375 |
| 104 | response to type I interferon (GO:0034340) | 2.37015749 |
| 105 | interleukin-1-mediated signaling pathway (GO:0070498) | 2.36814722 |
| 106 | CD4-positive, alpha-beta T cell differentiation (GO:0043367) | 2.36290623 |
| 107 | positive regulation of triglyceride lipase activity (GO:0061365) | 2.36083590 |
| 108 | positive regulation of lipoprotein lipase activity (GO:0051006) | 2.36083590 |
| 109 | macromolecular complex disassembly (GO:0032984) | 2.35402152 |
| 110 | endosome to melanosome transport (GO:0035646) | 2.34401444 |
| 111 | endosome to pigment granule transport (GO:0043485) | 2.34401444 |
| 112 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 2.34105993 |
| 113 | antigen processing and presentation of endogenous antigen (GO:0019883) | 2.33742547 |
| 114 | ceramide catabolic process (GO:0046514) | 2.32606259 |
| 115 | oligosaccharide catabolic process (GO:0009313) | 2.32306205 |
| 116 | negative regulation of inflammatory response to antigenic stimulus (GO:0002862) | 2.31626769 |
| 117 | leukocyte apoptotic process (GO:0071887) | 2.31593448 |
| 118 | germinal center formation (GO:0002467) | 2.31573177 |
| 119 | regulation of T cell tolerance induction (GO:0002664) | 2.31534849 |
| 120 | mature B cell differentiation involved in immune response (GO:0002313) | 2.31459244 |
| 121 | mitotic recombination (GO:0006312) | 2.31330863 |
| 122 | purinergic nucleotide receptor signaling pathway (GO:0035590) | 2.30975431 |
| 123 | type I interferon signaling pathway (GO:0060337) | 2.30966192 |
| 124 | cellular response to type I interferon (GO:0071357) | 2.30966192 |
| 125 | mesenchymal-epithelial cell signaling (GO:0060638) | 2.30286480 |
| 126 | telomere maintenance via recombination (GO:0000722) | 2.30144146 |
| 127 | detection of bacterium (GO:0016045) | 2.30140349 |
| 128 | pyrimidine nucleoside monophosphate biosynthetic process (GO:0009130) | 2.29695949 |
| 129 | negative regulation of granulocyte differentiation (GO:0030853) | 2.29623705 |
| 130 | positive regulation of smooth muscle cell migration (GO:0014911) | 2.28938342 |
| 131 | regulation of interleukin-12 biosynthetic process (GO:0045075) | 2.28895788 |
| 132 | interferon-gamma production (GO:0032609) | 2.28019588 |
| 133 | regulation of activation of Janus kinase activity (GO:0010533) | 2.27346987 |
| 134 | alpha-beta T cell differentiation involved in immune response (GO:0002293) | 2.27208494 |
| 135 | alpha-beta T cell activation involved in immune response (GO:0002287) | 2.27208494 |
| 136 | T cell differentiation involved in immune response (GO:0002292) | 2.27208494 |
| 137 | GDP-mannose metabolic process (GO:0019673) | 2.26874967 |
| 138 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 2.26740703 |
| 139 | regulation of humoral immune response mediated by circulating immunoglobulin (GO:0002923) | 2.26585414 |
| 140 | pentose metabolic process (GO:0019321) | 2.25968591 |
| 141 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 2.25450060 |
| 142 | T cell migration (GO:0072678) | 2.24457775 |
| 143 | regulation of necroptotic process (GO:0060544) | 2.24441294 |
| 144 | regulation of T cell mediated cytotoxicity (GO:0001914) | 2.24265497 |
| 145 | positive regulation of fatty acid biosynthetic process (GO:0045723) | 2.24080372 |
| 146 | detection of external biotic stimulus (GO:0098581) | 2.23434149 |
| 147 | neutrophil activation (GO:0042119) | 2.22779315 |
| 148 | response to interferon-alpha (GO:0035455) | 2.22641491 |
| 149 | macrophage activation (GO:0042116) | 2.22150151 |
| 150 | positive regulation of chemokine biosynthetic process (GO:0045080) | 2.21161838 |
| 151 | proline biosynthetic process (GO:0006561) | 2.20570749 |
| 152 | amyloid precursor protein catabolic process (GO:0042987) | 2.19734110 |
| 153 | granulocyte activation (GO:0036230) | 2.19508164 |
| 154 | cell redox homeostasis (GO:0045454) | 2.19330018 |
| 155 | T-helper 1 type immune response (GO:0042088) | 2.18353137 |
| 156 | DNA strand elongation involved in DNA replication (GO:0006271) | 2.18168619 |
| 157 | positive regulation of humoral immune response (GO:0002922) | 2.18072613 |
| 158 | nuclear-transcribed mRNA catabolic process (GO:0000956) | 2.18069273 |
| 159 | aminoglycoside antibiotic metabolic process (GO:0030647) | 2.17894249 |
| 160 | positive regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S tr | 2.17704033 |
| 161 | erythrose 4-phosphate/phosphoenolpyruvate family amino acid catabolic process (GO:1902222) | 2.17546384 |
| 162 | L-phenylalanine catabolic process (GO:0006559) | 2.17546384 |
| 163 | kinetochore organization (GO:0051383) | 2.16691891 |
| 164 | tryptophan metabolic process (GO:0006568) | 2.16639396 |
| 165 | DNA strand elongation (GO:0022616) | 2.16279880 |
| 166 | cellular component biogenesis (GO:0044085) | 2.16175524 |
| 167 | regulation of gamma-delta T cell activation (GO:0046643) | 2.16088596 |
| 168 | positive regulation of natural killer cell activation (GO:0032816) | 2.15931168 |
| 169 | toxin transport (GO:1901998) | 2.15494672 |
| 170 | positive regulation of antigen processing and presentation (GO:0002579) | 2.14996519 |
| 171 | negative regulation of nitric oxide biosynthetic process (GO:0045019) | 2.14550014 |
| 172 | peptidyl-glutamic acid carboxylation (GO:0017187) | 2.13964157 |
| 173 | protein carboxylation (GO:0018214) | 2.13964157 |
| 174 | regulation of natural killer cell differentiation (GO:0032823) | 2.13852038 |
| 175 | lymph node development (GO:0048535) | 2.13469362 |
| 176 | chaperone-mediated protein transport (GO:0072321) | 2.13360195 |
| 177 | oxidative phosphorylation (GO:0006119) | 2.13203552 |
| 178 | angiotensin maturation (GO:0002003) | 2.12787888 |
| 179 | regulation of vitamin D biosynthetic process (GO:0060556) | 2.12767975 |
| 180 | energy coupled proton transport, down electrochemical gradient (GO:0015985) | 2.12653256 |
| 181 | ATP synthesis coupled proton transport (GO:0015986) | 2.12653256 |
| 182 | regulation of RIG-I signaling pathway (GO:0039535) | 2.12497379 |
| 183 | mature B cell differentiation (GO:0002335) | 2.12497297 |
| 184 | deoxyribose phosphate metabolic process (GO:0019692) | 2.11726192 |
| 185 | positive regulation of acute inflammatory response (GO:0002675) | 2.11614229 |
| 186 | nucleoside salvage (GO:0043174) | 2.10703109 |
| 187 | regulation of cyclin-dependent protein serine/threonine kinase activity involved in G1/S transition | 2.10499285 |
| 188 | detection of biotic stimulus (GO:0009595) | 2.10404417 |
| 189 | pinocytosis (GO:0006907) | 2.10361742 |
| 190 | I-kappaB phosphorylation (GO:0007252) | 2.09932649 |
| 191 | myeloid dendritic cell activation (GO:0001773) | 2.09677799 |
| 192 | cytokine secretion (GO:0050663) | 2.07847606 |
| 193 | positive regulation of interleukin-2 biosynthetic process (GO:0045086) | 2.07300751 |
| 194 | positive regulation of type I interferon-mediated signaling pathway (GO:0060340) | 2.06822936 |
| 195 | myeloid cell activation involved in immune response (GO:0002275) | 2.06557710 |
| 196 | hydrogen peroxide biosynthetic process (GO:0050665) | 2.05150334 |
| 197 | monocyte chemotaxis (GO:0002548) | 2.05079500 |
| 198 | CD4-positive, alpha-beta T cell activation (GO:0035710) | 2.03975143 |
| 199 | response to host immune response (GO:0052572) | 2.03824241 |
| 200 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 2.03824241 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | E2F7_22180533_ChIP-Seq_HELA_Human | 4.69258018 |
| 2 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 4.20107635 |
| 3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 3.85474839 |
| 4 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 3.43280239 |
| 5 | TCF21_23034159_ChIP-ChIP_E13_GONADS_Rat | 3.18882684 |
| 6 | TP63_17297297_ChIP-ChIP_HaCaT_Human | 2.98917091 |
| 7 | GATA1_22025678_ChIP-Seq_K562_Human | 2.98705222 |
| 8 | MYC_18555785_ChIP-Seq_MESCs_Mouse | 2.94180521 |
| 9 | IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 2.91726039 |
| 10 | ELF1_17652178_ChIP-ChIP_JURKAT_Human | 2.87574273 |
| 11 | EKLF_21900194_ChIP-Seq_ERYTHROCYTE_Mouse | 2.84471498 |
| 12 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.79006939 |
| 13 | JARID1A_20064375_ChIP-Seq_MESCs_Mouse | 2.58361257 |
| 14 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 2.56877225 |
| 15 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 2.42167229 |
| 16 | * MYC_18358816_ChIP-ChIP_MESCs_Mouse | 2.40230197 |
| 17 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 2.40100021 |
| 18 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 2.36685106 |
| 19 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 2.35694480 |
| 20 | Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 2.31847406 |
| 21 | * STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 2.30235296 |
| 22 | KDM6A_18722178_ChIP-ChIP_U937_AND_SAOS2_Human | 2.27779219 |
| 23 | GABP_17652178_ChIP-ChIP_JURKAT_Human | 2.23297136 |
| 24 | HCFC1_20581084_ChIP-Seq_MESCs_Mouse | 2.22341413 |
| 25 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 2.19165294 |
| 26 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.11807743 |
| 27 | * CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 2.08659962 |
| 28 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 2.05847578 |
| 29 | ETS1_20019798_ChIP-Seq_JURKAT_Human | 2.00119867 |
| 30 | SPI1_22790984_ChIP-Seq_ERYTHROLEUKEMIA_Mouse | 1.96352742 |
| 31 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 1.95402966 |
| 32 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.93498798 |
| 33 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 1.93177994 |
| 34 | * NELFA_20434984_ChIP-Seq_ESCs_Mouse | 1.91914429 |
| 35 | VDR_21846776_ChIP-Seq_THP-1_Human | 1.90478987 |
| 36 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.90071561 |
| 37 | CREB1_15753290_ChIP-ChIP_HEK293T_Human | 1.87441888 |
| 38 | E2F1_18555785_ChIP-Seq_MESCs_Mouse | 1.85175623 |
| 39 | MYC_19030024_ChIP-ChIP_MESCs_Mouse | 1.84448697 |
| 40 | DCP1A_22483619_ChIP-Seq_HELA_Human | 1.84015336 |
| 41 | CEBPA_23403033_ChIP-Seq_LIVER_Mouse | 1.83367513 |
| 42 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 1.83247739 |
| 43 | CEBPB_23403033_ChIP-Seq_LIVER_Mouse | 1.81268287 |
| 44 | EGR1_23403033_ChIP-Seq_LIVER_Mouse | 1.80955238 |
| 45 | * CHD1_19587682_ChIP-ChIP_MESCs_Mouse | 1.80428491 |
| 46 | ZFX_18555785_ChIP-Seq_MESCs_Mouse | 1.77996236 |
| 47 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.77033478 |
| 48 | ERG_20887958_ChIP-Seq_HPC-7_Mouse | 1.76203073 |
| 49 | * CEBPB_24764292_ChIP-Seq_MC3T3_Mouse | 1.75778266 |
| 50 | * GABP_19822575_ChIP-Seq_HepG2_Human | 1.75687964 |
| 51 | * HOXB4_20404135_ChIP-ChIP_EML_Mouse | 1.72449039 |
| 52 | FOXA1_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 1.69778032 |
| 53 | GBX2_23144817_ChIP-Seq_PC3_Human | 1.69439314 |
| 54 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.67734493 |
| 55 | TAL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.66725467 |
| 56 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.66593993 |
| 57 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 1.61978054 |
| 58 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.61317367 |
| 59 | SFPI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.61175077 |
| 60 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.60374028 |
| 61 | FOXO3_22982991_ChIP-Seq_MACROPHAGES_Mouse | 1.59377953 |
| 62 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 1.58565228 |
| 63 | FOXP3_21729870_ChIP-Seq_TREG_Human | 1.58549532 |
| 64 | XRN2_22483619_ChIP-Seq_HELA_Human | 1.56661675 |
| 65 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.56283852 |
| 66 | SRF_21415370_ChIP-Seq_HL-1_Mouse | 1.55761431 |
| 67 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.54533287 |
| 68 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.53206301 |
| 69 | FLI1_20887958_ChIP-Seq_HPC-7_Mouse | 1.51703925 |
| 70 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.51332225 |
| 71 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.50605757 |
| 72 | MYC_19079543_ChIP-ChIP_MESCs_Mouse | 1.50200284 |
| 73 | FOXM1_25889361_ChIP-Seq_OE33_AND_U2OS_Human | 1.50013925 |
| 74 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.48869935 |
| 75 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.48644897 |
| 76 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.47572873 |
| 77 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.47374161 |
| 78 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.47059864 |
| 79 | VDR_24787735_ChIP-Seq_THP-1_Human | 1.46954762 |
| 80 | TTF2_22483619_ChIP-Seq_HELA_Human | 1.45736155 |
| 81 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.44799150 |
| 82 | DACH1_20351289_ChIP-Seq_MDA-MB-231_Human | 1.44478587 |
| 83 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.43932964 |
| 84 | PPARG_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.42873403 |
| 85 | * FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 1.42184983 |
| 86 | VDR_23849224_ChIP-Seq_CD4+_Human | 1.41488445 |
| 87 | ELK1_19687146_ChIP-ChIP_HELA_Human | 1.40641596 |
| 88 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 1.40171407 |
| 89 | EST1_17652178_ChIP-ChIP_JURKAT_Human | 1.39638448 |
| 90 | TP53_18474530_ChIP-ChIP_U2OS_Human | 1.39090940 |
| 91 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.38629005 |
| 92 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.38116483 |
| 93 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.36621449 |
| 94 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 1.36615639 |
| 95 | AR_21909140_ChIP-Seq_LNCAP_Human | 1.36112736 |
| 96 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.36044870 |
| 97 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.35464638 |
| 98 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.35464638 |
| 99 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.34428040 |
| 100 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.32345816 |
| 101 | ESR1_15608294_ChIP-ChIP_MCF-7_Human | 1.31623474 |
| 102 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.30559758 |
| 103 | TP53_16413492_ChIP-PET_HCT116_Human | 1.30168561 |
| 104 | KDM5A_27292631_Chip-Seq_BREAST_Human | 1.30028744 |
| 105 | E2F4_17652178_ChIP-ChIP_JURKAT_Human | 1.29993726 |
| 106 | * MYCN_18555785_ChIP-Seq_MESCs_Mouse | 1.29978757 |
| 107 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.29174155 |
| 108 | CJUN_26792858_Chip-Seq_BT549_Human | 1.28777950 |
| 109 | SPI1_23547873_ChIP-Seq_NB4_Human | 1.27429070 |
| 110 | PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.27077783 |
| 111 | * EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.25526845 |
| 112 | MYB_21317192_ChIP-Seq_ERMYB_Mouse | 1.24875699 |
| 113 | HNF4A_19761587_ChIP-ChIP_CACO-2_Human | 1.24072036 |
| 114 | * CNOT3_19339689_ChIP-ChIP_MESCs_Mouse | 1.23985137 |
| 115 | PDX1_19855005_ChIP-ChIP_MIN6_Mouse | 1.22344067 |
| 116 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.22217210 |
| 117 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.21892979 |
| 118 | NOTCH1_21737748_ChIP-Seq_TLL_Human | 1.21569834 |
| 119 | NCOR1_26117541_ChIP-Seq_K562_Human | 1.20701761 |
| 120 | * SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.20633205 |
| 121 | VDR_24763502_ChIP-Seq_THP-1_Human | 1.19807398 |
| 122 | * P53_22387025_ChIP-Seq_ESCs_Mouse | 1.19043101 |
| 123 | E2F1_21310950_ChIP-Seq_MCF-7_Human | 1.18925366 |
| 124 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.18837722 |
| 125 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.18275377 |
| 126 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 1.18210640 |
| 127 | * TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.18133776 |
| 128 | * NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.16194737 |
| 129 | CCND1_20090754_ChIP-ChIP_RETINA_Mouse | 1.16075929 |
| 130 | BCL11B_21912641_ChIP-Seq_STHDH_STRIUM_Mouse | 1.16039054 |
| 131 | * KLF4_18555785_ChIP-Seq_MESCs_Mouse | 1.13523237 |
| 132 | ASXL1_24218140_ChIP-Seq_BMDM_Mouse | 1.13510626 |
| 133 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.13343863 |
| 134 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.12123391 |
| 135 | * E2F4_21247883_ChIP-Seq_LYMPHOBLASTOID_Human | 1.11799950 |
| 136 | GFI1B_20887958_ChIP-Seq_HPC-7_Mouse | 1.11720357 |
| 137 | * SUZ12_18555785_Chip-Seq_ESCs_Mouse | 1.11506397 |
| 138 | * STAT3_18555785_Chip-Seq_ESCs_Mouse | 1.10817181 |
| 139 | THAP11_20581084_ChIP-Seq_MESCs_Mouse | 1.10590179 |
| 140 | * PU1_27457419_Chip-Seq_LIVER_Mouse | 1.10220456 |
| 141 | * P300_19829295_ChIP-Seq_ESCs_Human | 1.10174937 |
| 142 | * E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.08868179 |
| 143 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.05475179 |
| 144 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.04926927 |
| 145 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.04727967 |
| 146 | * CTCF_18555785_ChIP-Seq_MESCs_Mouse | 1.04707750 |
| 147 | * NMYC_18555785_Chip-Seq_ESCs_Mouse | 1.04473963 |
| 148 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.04035105 |
| 149 | * CMYC_18555785_Chip-Seq_ESCs_Mouse | 1.02376836 |
| 150 | * OCT4_18555785_Chip-Seq_ESCs_Mouse | 1.01898280 |
| 151 | * EBF1_22473956_ChIP-Seq_LYMPHODE_Mouse | 1.01360557 |
| 152 | * ELK3_25401928_ChIP-Seq_HUVEC_Human | 1.01262005 |
| 153 | * ZFP42_18358816_ChIP-ChIP_MESCs_Mouse | 1.01170657 |
| 154 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.00992816 |
| 155 | GATA2_22383799_ChIP-Seq_G1ME_Mouse | 1.00969973 |
| 156 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.00577138 |
| 157 | GATA1_22383799_ChIP-Seq_G1ME_Mouse | 1.00049331 |
| 158 | SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 0.99369898 |
| 159 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.99118932 |
| 160 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.98894673 |
| 161 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 0.98753107 |
| 162 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.98354119 |
| 163 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.97978902 |
| 164 | P300_18555785_Chip-Seq_ESCs_Mouse | 0.97442581 |
| 165 | HSF1_23293686_ChIP-Seq_STHDH_STRIATAL_Mouse | 0.96517937 |
| 166 | * SOX2_18555785_Chip-Seq_ESCs_Mouse | 0.95718998 |
| 167 | RUNX1_27457419_Chip-Seq_LIVER_Mouse | 0.95713587 |
| 168 | RUNX1_17652178_ChIP-ChIP_JURKAT_Human | 0.95217416 |
| 169 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.95166026 |
| 170 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.95113630 |
| 171 | TBX5_21415370_ChIP-Seq_HL-1_Mouse | 0.94911868 |
| 172 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94666747 |
| 173 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 0.94461202 |
| 174 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.94398697 |
| 175 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 0.93948947 |
| 176 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93935939 |
| 177 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.93838757 |
| 178 | SRY_22984422_ChIP-ChIP_TESTIS_Rat | 0.93769151 |
| 179 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.92973560 |
| 180 | MYB_26560356_Chip-Seq_TH2_Human | 0.91744714 |
| 181 | ESRRB_18555785_Chip-Seq_ESCs_Mouse | 0.91494803 |
| 182 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.91478067 |
| 183 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 0.91403797 |
| 184 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 0.90736407 |
| 185 | SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.90589131 |
| 186 | SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.90589131 |
| 187 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.90195260 |
| 188 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 0.88703111 |
| 189 | SOX2_20726797_ChIP-Seq_SW620_Human | 0.88037856 |
| 190 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.88026074 |
| 191 | * SMAD1_18555785_Chip-Seq_ESCs_Mouse | 0.87825964 |
| 192 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.87205276 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0009379_abnormal_foot_pigmentation | 3.48733830 |
| 2 | MP0009840_abnormal_foam_cell | 3.30399909 |
| 3 | MP0009278_abnormal_bone_marrow | 3.10582511 |
| 4 | MP0001835_abnormal_antigen_presentation | 2.94291141 |
| 5 | MP0003724_increased_susceptibility_to | 2.84910288 |
| 6 | MP0003806_abnormal_nucleotide_metabolis | 2.77958584 |
| 7 | MP0005451_abnormal_body_composition | 2.58374493 |
| 8 | MP0003436_decreased_susceptibility_to | 2.47252816 |
| 9 | MP0003186_abnormal_redox_activity | 2.43942867 |
| 10 | MP0002166_altered_tumor_susceptibility | 2.41952480 |
| 11 | MP0005397_hematopoietic_system_phenotyp | 2.36729157 |
| 12 | MP0001545_abnormal_hematopoietic_system | 2.36729157 |
| 13 | MP0002419_abnormal_innate_immunity | 2.25808835 |
| 14 | MP0000569_abnormal_digit_pigmentation | 2.25230184 |
| 15 | MP0005671_abnormal_response_to | 2.23349440 |
| 16 | MP0002138_abnormal_hepatobiliary_system | 2.22137462 |
| 17 | MP0002006_tumorigenesis | 2.16659462 |
| 18 | MP0009785_altered_susceptibility_to | 2.13626904 |
| 19 | MP0008438_abnormal_cutaneous_collagen | 2.12281601 |
| 20 | MP0002148_abnormal_hypersensitivity_rea | 2.11868340 |
| 21 | MP0005000_abnormal_immune_tolerance | 1.97419012 |
| 22 | MP0001790_abnormal_immune_system | 1.95945338 |
| 23 | MP0005387_immune_system_phenotype | 1.95945338 |
| 24 | MP0009384_cardiac_valve_regurgitation | 1.89117811 |
| 25 | MP0006082_CNS_inflammation | 1.87814181 |
| 26 | MP0003252_abnormal_bile_duct | 1.84370790 |
| 27 | MP0005025_abnormal_response_to | 1.78558254 |
| 28 | MP0003045_fibrosis | 1.77273660 |
| 29 | MP0002452_abnormal_antigen_presenting | 1.75797223 |
| 30 | MP0005503_abnormal_tendon_morphology | 1.75760246 |
| 31 | MP0005464_abnormal_platelet_physiology | 1.75519601 |
| 32 | MP0002998_abnormal_bone_remodeling | 1.75497336 |
| 33 | MP0010234_abnormal_vibrissa_follicle | 1.71349646 |
| 34 | MP0005058_abnormal_lysosome_morphology | 1.71054625 |
| 35 | MP0005365_abnormal_bile_salt | 1.69505463 |
| 36 | MP0010030_abnormal_orbit_morphology | 1.68394606 |
| 37 | MP0002009_preneoplasia | 1.67490275 |
| 38 | MP0001800_abnormal_humoral_immune | 1.65696190 |
| 39 | MP0005220_abnormal_exocrine_pancreas | 1.63538816 |
| 40 | MP0005174_abnormal_tail_pigmentation | 1.63215226 |
| 41 | MP0002723_abnormal_immune_serum | 1.63005994 |
| 42 | MP0004381_abnormal_hair_follicle | 1.60609323 |
| 43 | MP0009764_decreased_sensitivity_to | 1.60145503 |
| 44 | MP0003300_gastrointestinal_ulcer | 1.59229917 |
| 45 | MP0003656_abnormal_erythrocyte_physiolo | 1.57952030 |
| 46 | MP0008260_abnormal_autophagy | 1.57586562 |
| 47 | MP0003183_abnormal_peptide_metabolism | 1.54009870 |
| 48 | MP0000685_abnormal_immune_system | 1.50675007 |
| 49 | MP0001533_abnormal_skeleton_physiology | 1.49169436 |
| 50 | MP0000015_abnormal_ear_pigmentation | 1.47773472 |
| 51 | MP0001819_abnormal_immune_cell | 1.47728367 |
| 52 | MP0002420_abnormal_adaptive_immunity | 1.47720030 |
| 53 | MP0002877_abnormal_melanocyte_morpholog | 1.46818753 |
| 54 | MP0001881_abnormal_mammary_gland | 1.44497574 |
| 55 | MP0002653_abnormal_ependyma_morphology | 1.44446245 |
| 56 | MP0003279_aneurysm | 1.42062024 |
| 57 | MP0005360_urolithiasis | 1.41276146 |
| 58 | MP0005408_hypopigmentation | 1.39997648 |
| 59 | MP0002933_joint_inflammation | 1.39931599 |
| 60 | MP0005501_abnormal_skin_physiology | 1.38453690 |
| 61 | MP0000465_gastrointestinal_hemorrhage | 1.37862253 |
| 62 | MP0001873_stomach_inflammation | 1.37551983 |
| 63 | MP0003763_abnormal_thymus_physiology | 1.36249449 |
| 64 | MP0003172_abnormal_lysosome_physiology | 1.34956211 |
| 65 | MP0003868_abnormal_feces_composition | 1.32798003 |
| 66 | MP0002928_abnormal_bile_duct | 1.32331051 |
| 67 | MP0009697_abnormal_copulation | 1.28165206 |
| 68 | MP0008057_abnormal_DNA_replication | 1.26347542 |
| 69 | MP0004272_abnormal_basement_membrane | 1.26178601 |
| 70 | MP0001188_hyperpigmentation | 1.25907280 |
| 71 | MP0001845_abnormal_inflammatory_respons | 1.24150103 |
| 72 | MP0008004_abnormal_stomach_pH | 1.24007088 |
| 73 | MP0008007_abnormal_cellular_replicative | 1.23707479 |
| 74 | MP0008469_abnormal_protein_level | 1.21158818 |
| 75 | MP0010094_abnormal_chromosome_stability | 1.20769008 |
| 76 | MP0005075_abnormal_melanosome_morpholog | 1.19581334 |
| 77 | MP0005319_abnormal_enzyme/_coenzyme | 1.19531624 |
| 78 | MP0001727_abnormal_embryo_implantation | 1.19422996 |
| 79 | MP0003195_calcinosis | 1.19376430 |
| 80 | MP0004947_skin_inflammation | 1.18973386 |
| 81 | MP0003786_premature_aging | 1.18943698 |
| 82 | MP0002254_reproductive_system_inflammat | 1.18411516 |
| 83 | MP0000371_diluted_coat_color | 1.17805290 |
| 84 | MP0004808_abnormal_hematopoietic_stem | 1.17348703 |
| 85 | MP0010155_abnormal_intestine_physiology | 1.14708367 |
| 86 | MP0000767_abnormal_smooth_muscle | 1.12558136 |
| 87 | MP0001764_abnormal_homeostasis | 1.12198898 |
| 88 | MP0001879_abnormal_lymphatic_vessel | 1.12026253 |
| 89 | MP0005085_abnormal_gallbladder_physiolo | 1.11881261 |
| 90 | MP0005171_absent_coat_pigmentation | 1.11493540 |
| 91 | MP0002396_abnormal_hematopoietic_system | 1.10941428 |
| 92 | MP0004957_abnormal_blastocyst_morpholog | 1.10553412 |
| 93 | MP0002405_respiratory_system_inflammati | 1.10543759 |
| 94 | MP0001666_abnormal_nutrient_absorption | 1.10374799 |
| 95 | MP0002277_abnormal_respiratory_mucosa | 1.09323982 |
| 96 | MP0003828_pulmonary_edema | 1.09154144 |
| 97 | MP0004264_abnormal_extraembryonic_tissu | 1.08762466 |
| 98 | MP0004510_myositis | 1.07874954 |
| 99 | MP0005390_skeleton_phenotype | 1.06655362 |
| 100 | MP0008932_abnormal_embryonic_tissue | 1.06630465 |
| 101 | MP0006054_spinal_hemorrhage | 1.04943345 |
| 102 | MP0002796_impaired_skin_barrier | 1.04670769 |
| 103 | MP0002693_abnormal_pancreas_physiology | 1.03627805 |
| 104 | MP0002139_abnormal_hepatobiliary_system | 1.02907643 |
| 105 | MP0001216_abnormal_epidermal_layer | 1.02678155 |
| 106 | MP0002168_other_aberrant_phenotype | 1.02465533 |
| 107 | MP0000383_abnormal_hair_follicle | 1.01572541 |
| 108 | MP0000716_abnormal_immune_system | 1.01173088 |
| 109 | MP0008058_abnormal_DNA_repair | 1.00711715 |
| 110 | MP0005257_abnormal_intraocular_pressure | 1.00615248 |
| 111 | MP0009333_abnormal_splenocyte_physiolog | 1.00357530 |
| 112 | MP0002060_abnormal_skin_morphology | 0.99906814 |
| 113 | MP0006036_abnormal_mitochondrial_physio | 0.99846271 |
| 114 | MP0003453_abnormal_keratinocyte_physiol | 0.98718565 |
| 115 | MP0000627_abnormal_mammary_gland | 0.98526407 |
| 116 | MP0004782_abnormal_surfactant_physiolog | 0.96824003 |
| 117 | MP0003795_abnormal_bone_structure | 0.96244901 |
| 118 | MP0000609_abnormal_liver_physiology | 0.96128292 |
| 119 | MP0000678_abnormal_parathyroid_gland | 0.94641783 |
| 120 | MP0003718_maternal_effect | 0.94597422 |
| 121 | MP0010368_abnormal_lymphatic_system | 0.94480128 |
| 122 | MP0005084_abnormal_gallbladder_morpholo | 0.94410067 |
| 123 | MP0005083_abnormal_biliary_tract | 0.91064411 |
| 124 | MP0001346_abnormal_lacrimal_gland | 0.90055346 |
| 125 | MP0003690_abnormal_glial_cell | 0.89819490 |
| 126 | MP0000598_abnormal_liver_morphology | 0.88872325 |
| 127 | MP0003191_abnormal_cellular_cholesterol | 0.88310754 |
| 128 | MP0008789_abnormal_olfactory_epithelium | 0.87429140 |
| 129 | MP0003303_peritoneal_inflammation | 0.87298742 |
| 130 | MP0003111_abnormal_nucleus_morphology | 0.86723069 |
| 131 | MP0009643_abnormal_urine_homeostasis | 0.86177921 |
| 132 | MP0002398_abnormal_bone_marrow | 0.85734850 |
| 133 | MP0009763_increased_sensitivity_to | 0.85203289 |
| 134 | MP0000681_abnormal_thyroid_gland | 0.85002029 |
| 135 | MP0003136_yellow_coat_color | 0.84841124 |
| 136 | MP0005310_abnormal_salivary_gland | 0.83094144 |
| 137 | MP0005409_darkened_coat_color | 0.82913104 |
| 138 | MP0000858_altered_metastatic_potential | 0.82894412 |
| 139 | MP0005023_abnormal_wound_healing | 0.82796413 |
| 140 | MP0003941_abnormal_skin_development | 0.82144646 |
| 141 | MP0010386_abnormal_urinary_bladder | 0.81877370 |
| 142 | MP0003448_altered_tumor_morphology | 0.81337689 |
| 143 | MP0003693_abnormal_embryo_hatching | 0.80778592 |
| 144 | MP0001243_abnormal_dermal_layer | 0.80670962 |
| 145 | MP0003566_abnormal_cell_adhesion | 0.79228080 |
| 146 | MP0005275_abnormal_skin_tensile | 0.78721546 |
| 147 | MP0000358_abnormal_cell_content/ | 0.78077412 |
| 148 | MP0000490_abnormal_crypts_of | 0.77305166 |
| 149 | MP0001958_emphysema | 0.77144387 |
| 150 | MP0001853_heart_inflammation | 0.77044559 |
| 151 | MP0005670_abnormal_white_adipose | 0.76522107 |
| 152 | MP0000249_abnormal_blood_vessel | 0.75506631 |
| 153 | MP0002098_abnormal_vibrissa_morphology | 0.75111802 |
| 154 | MP0000343_altered_response_to | 0.73988188 |
| 155 | MP0002019_abnormal_tumor_incidence | 0.73932538 |
| 156 | MP0002295_abnormal_pulmonary_circulatio | 0.70780512 |
| 157 | MP0008875_abnormal_xenobiotic_pharmacok | 0.70203861 |
| 158 | MP0009765_abnormal_xenobiotic_induced | 0.69058548 |
| 159 | MP0001661_extended_life_span | 0.67643540 |
| 160 | MP0002970_abnormal_white_adipose | 0.67304455 |
| 161 | MP0010678_abnormal_skin_adnexa | 0.66961519 |
| 162 | MP0001542_abnormal_bone_strength | 0.65592110 |
| 163 | MP0005508_abnormal_skeleton_morphology | 0.65185467 |
| 164 | MP0002429_abnormal_blood_cell | 0.65009710 |
| 165 | MP0010771_integument_phenotype | 0.64321753 |
| 166 | MP0005410_abnormal_fertilization | 0.63564785 |
| 167 | MP0005332_abnormal_amino_acid | 0.61574303 |
| 168 | MP0000377_abnormal_hair_follicle | 0.61571080 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Eczematoid dermatitis (HP:0000976) | 3.75327047 |
| 2 | Aplasia/Hypoplasia of the sacrum (HP:0008517) | 3.54294359 |
| 3 | Recurrent gram-negative bacterial infections (HP:0005420) | 3.49046651 |
| 4 | Beaking of vertebral bodies (HP:0004568) | 3.37647219 |
| 5 | Reticulocytopenia (HP:0001896) | 3.35921655 |
| 6 | Joint hemorrhage (HP:0005261) | 3.28028212 |
| 7 | Vertebral compression fractures (HP:0002953) | 3.18569568 |
| 8 | Recurrent abscess formation (HP:0002722) | 3.10519839 |
| 9 | Recurrent bacterial skin infections (HP:0005406) | 3.03712279 |
| 10 | Prolonged partial thromboplastin time (HP:0003645) | 2.93925922 |
| 11 | Metaphyseal dysplasia (HP:0100255) | 2.84404569 |
| 12 | Gingival bleeding (HP:0000225) | 2.84162516 |
| 13 | Vacuolated lymphocytes (HP:0001922) | 2.79746365 |
| 14 | Spondylolisthesis (HP:0003302) | 2.74797087 |
| 15 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.73464621 |
| 16 | Acute encephalopathy (HP:0006846) | 2.70818901 |
| 17 | Cerebral edema (HP:0002181) | 2.67531274 |
| 18 | Recurrent fungal infections (HP:0002841) | 2.67338240 |
| 19 | Abnormality of aromatic amino acid family metabolism (HP:0004338) | 2.65825728 |
| 20 | Optic neuritis (HP:0100653) | 2.64747403 |
| 21 | Retrobulbar optic neuritis (HP:0100654) | 2.64747403 |
| 22 | Orchitis (HP:0100796) | 2.64269859 |
| 23 | Myositis (HP:0100614) | 2.64024458 |
| 24 | Microretrognathia (HP:0000308) | 2.63173549 |
| 25 | Acute necrotizing encephalopathy (HP:0006965) | 2.60646996 |
| 26 | Abnormal activity of mitochondrial respiratory chain (HP:0011922) | 2.58797826 |
| 27 | Decreased activity of mitochondrial respiratory chain (HP:0008972) | 2.58797826 |
| 28 | Periodontitis (HP:0000704) | 2.58535116 |
| 29 | Abnormality of cells of the erythroid lineage (HP:0012130) | 2.57880833 |
| 30 | Hyperthyroidism (HP:0000836) | 2.54670573 |
| 31 | Prostate neoplasm (HP:0100787) | 2.53960910 |
| 32 | Epistaxis (HP:0000421) | 2.51974022 |
| 33 | Macrocytic anemia (HP:0001972) | 2.50591351 |
| 34 | Cervical subluxation (HP:0003308) | 2.47695390 |
| 35 | Chronic diarrhea (HP:0002028) | 2.44007516 |
| 36 | Onycholysis (HP:0001806) | 2.43163193 |
| 37 | Lip pit (HP:0100267) | 2.43036019 |
| 38 | Broad face (HP:0000283) | 2.41930091 |
| 39 | Dysostosis multiplex (HP:0000943) | 2.40815546 |
| 40 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.36540442 |
| 41 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.36540442 |
| 42 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.36540442 |
| 43 | Myocardial infarction (HP:0001658) | 2.34839470 |
| 44 | Renal cortical cysts (HP:0000803) | 2.33636087 |
| 45 | Abnormality of the intrinsic pathway (HP:0010989) | 2.32694669 |
| 46 | Thrombocytosis (HP:0001894) | 2.32653559 |
| 47 | Hepatocellular necrosis (HP:0001404) | 2.30194989 |
| 48 | Recurrent viral infections (HP:0004429) | 2.29868811 |
| 49 | Hyperammonemia (HP:0001987) | 2.29776034 |
| 50 | Aplasia/Hypoplasia involving the sinuses (HP:0009120) | 2.29512664 |
| 51 | Mitochondrial inheritance (HP:0001427) | 2.28960774 |
| 52 | Mediastinal lymphadenopathy (HP:0100721) | 2.28014962 |
| 53 | Prolonged bleeding time (HP:0003010) | 2.27360357 |
| 54 | Gingivitis (HP:0000230) | 2.27198035 |
| 55 | Petechiae (HP:0000967) | 2.26797756 |
| 56 | J-shaped sella turcica (HP:0002680) | 2.26794343 |
| 57 | Intrahepatic cholestasis (HP:0001406) | 2.23015804 |
| 58 | Hepatic necrosis (HP:0002605) | 2.22892414 |
| 59 | Menorrhagia (HP:0000132) | 2.21494569 |
| 60 | Increased muscle lipid content (HP:0009058) | 2.20853447 |
| 61 | Chronic hepatic failure (HP:0100626) | 2.19828953 |
| 62 | Urinary glycosaminoglycan excretion (HP:0003541) | 2.19638033 |
| 63 | Mucopolysacchariduria (HP:0008155) | 2.19638033 |
| 64 | Recurrent skin infections (HP:0001581) | 2.18684751 |
| 65 | Abnormality of the common coagulation pathway (HP:0010990) | 2.18638642 |
| 66 | Spontaneous hematomas (HP:0007420) | 2.16428057 |
| 67 | Abnormal pupillary function (HP:0007686) | 2.15983471 |
| 68 | Abnormal platelet function (HP:0011869) | 2.15479336 |
| 69 | Impaired platelet aggregation (HP:0003540) | 2.15479336 |
| 70 | Alveolar cell carcinoma (HP:0006519) | 2.14699698 |
| 71 | Abnormality of the renal cortex (HP:0011035) | 2.14088249 |
| 72 | 11 pairs of ribs (HP:0000878) | 2.13725291 |
| 73 | Autoimmune thrombocytopenia (HP:0001973) | 2.13350184 |
| 74 | Hypertensive crisis (HP:0100735) | 2.12646830 |
| 75 | Symptomatic seizures (HP:0011145) | 2.12166741 |
| 76 | Increased intramyocellular lipid droplets (HP:0012240) | 2.11669073 |
| 77 | Arterial thrombosis (HP:0004420) | 2.10355457 |
| 78 | Pulmonary infiltrates (HP:0002113) | 2.09401627 |
| 79 | Systemic lupus erythematosus (HP:0002725) | 2.08667912 |
| 80 | Fragile nails (HP:0001808) | 2.08511533 |
| 81 | Tubulointerstitial nephritis (HP:0001970) | 2.07757681 |
| 82 | Loss of speech (HP:0002371) | 2.06628063 |
| 83 | Vasculitis (HP:0002633) | 2.06574850 |
| 84 | Hypokinesia (HP:0002375) | 2.05230446 |
| 85 | Abnormality of the acetabulum (HP:0003170) | 2.05209447 |
| 86 | Thoracic kyphosis (HP:0002942) | 2.04683219 |
| 87 | Chronic mucocutaneous candidiasis (HP:0002728) | 2.04235589 |
| 88 | Recurrent cutaneous fungal infections (HP:0011370) | 2.04235589 |
| 89 | Abnormality of the fingertips (HP:0001211) | 2.04181511 |
| 90 | Progressive neurologic deterioration (HP:0002344) | 2.03056372 |
| 91 | Thick nail (HP:0001805) | 2.02627257 |
| 92 | Renal Fanconi syndrome (HP:0001994) | 2.02604620 |
| 93 | Aplasia/Hypoplasia of the frontal sinuses (HP:0009119) | 2.02577534 |
| 94 | Prolonged neonatal jaundice (HP:0006579) | 2.02081044 |
| 95 | Abnormality of the frontal sinuses (HP:0002687) | 2.01109527 |
| 96 | Abnormality of T cell number (HP:0011839) | 1.99302496 |
| 97 | Abnormal delayed hypersensitivity skin test (HP:0002963) | 1.98937342 |
| 98 | Hematochezia (HP:0002573) | 1.98458134 |
| 99 | Bruising susceptibility (HP:0000978) | 1.98293285 |
| 100 | Microglossia (HP:0000171) | 1.98222263 |
| 101 | Hypoglycemic seizures (HP:0002173) | 1.97937728 |
| 102 | Absent frontal sinuses (HP:0002688) | 1.96894389 |
| 103 | Orthostatic hypotension (HP:0001278) | 1.95907660 |
| 104 | Atrophic scars (HP:0001075) | 1.95691115 |
| 105 | Pallor (HP:0000980) | 1.95293494 |
| 106 | Increased CSF lactate (HP:0002490) | 1.95197338 |
| 107 | Conjugated hyperbilirubinemia (HP:0002908) | 1.94889761 |
| 108 | Abnormality of glycolysis (HP:0004366) | 1.92487582 |
| 109 | Neoplasm of the tracheobronchial system (HP:0100552) | 1.91849727 |
| 110 | Seborrheic dermatitis (HP:0001051) | 1.91633931 |
| 111 | Acute myeloid leukemia (HP:0004808) | 1.90641485 |
| 112 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 1.90050501 |
| 113 | Osteolytic defects of the hand bones (HP:0009699) | 1.90050501 |
| 114 | Complement deficiency (HP:0004431) | 1.89774380 |
| 115 | Craniofacial hyperostosis (HP:0004493) | 1.87682484 |
| 116 | Stomatitis (HP:0010280) | 1.87575283 |
| 117 | Cranial hyperostosis (HP:0004437) | 1.86304115 |
| 118 | Glomerulonephritis (HP:0000099) | 1.85513446 |
| 119 | T lymphocytopenia (HP:0005403) | 1.84821080 |
| 120 | Elevated erythrocyte sedimentation rate (HP:0003565) | 1.84621928 |
| 121 | Aortic regurgitation (HP:0001659) | 1.83832286 |
| 122 | Cardiomegaly (HP:0001640) | 1.83585637 |
| 123 | Portal hypertension (HP:0001409) | 1.83566440 |
| 124 | Villous atrophy (HP:0011473) | 1.83215727 |
| 125 | Abnormality of small intestinal villus morphology (HP:0011472) | 1.83215727 |
| 126 | Type I transferrin isoform profile (HP:0003642) | 1.81931367 |
| 127 | Premature rupture of membranes (HP:0001788) | 1.81907315 |
| 128 | Keratoconjunctivitis sicca (HP:0001097) | 1.81858482 |
| 129 | Abnormal hemoglobin (HP:0011902) | 1.81143154 |
| 130 | Abnormal gallbladder physiology (HP:0012438) | 1.80858829 |
| 131 | Cholecystitis (HP:0001082) | 1.80858829 |
| 132 | Abnormality of the nasal septum (HP:0000419) | 1.80481329 |
| 133 | Progressive macrocephaly (HP:0004481) | 1.78734422 |
| 134 | Nephritis (HP:0000123) | 1.78516279 |
| 135 | Lipid accumulation in hepatocytes (HP:0006561) | 1.77252341 |
| 136 | Abnormality of macrophages (HP:0004311) | 1.76949356 |
| 137 | Hypoparathyroidism (HP:0000829) | 1.75672082 |
| 138 | Obstructive lung disease (HP:0006536) | 1.75200428 |
| 139 | Chronic obstructive pulmonary disease (HP:0006510) | 1.75200428 |
| 140 | Biconcave vertebral bodies (HP:0004586) | 1.74718375 |
| 141 | Abnormality of the hepatic vasculature (HP:0006707) | 1.74030472 |
| 142 | Meningitis (HP:0001287) | 1.73329282 |
| 143 | Deformed sella turcica (HP:0002681) | 1.72581390 |
| 144 | Esophageal neoplasm (HP:0100751) | 1.71791024 |
| 145 | Neoplasm of head and neck (HP:0012288) | 1.71791024 |
| 146 | Chronic otitis media (HP:0000389) | 1.71453250 |
| 147 | Abnormality of homocysteine metabolism (HP:0010919) | 1.71431361 |
| 148 | Homocystinuria (HP:0002156) | 1.71431361 |
| 149 | Vertebral hypoplasia (HP:0008417) | 1.71207941 |
| 150 | Aplasia/Hypoplasia of the vertebrae (HP:0008515) | 1.71207941 |
| 151 | Purpura (HP:0000979) | 1.71073072 |
| 152 | Osteomyelitis (HP:0002754) | 1.70560367 |
| 153 | Abnormality of the prostate (HP:0008775) | 1.68505258 |
| 154 | Abnormality of complement system (HP:0005339) | 1.68084760 |
| 155 | Decreased circulating renin level (HP:0003351) | 1.67796282 |
| 156 | Abnormality of the thoracic spine (HP:0100711) | 1.67794909 |
| 157 | Axonal loss (HP:0003447) | 1.67516219 |
| 158 | Lactic acidosis (HP:0003128) | 1.67383249 |
| 159 | Cupped ribs (HP:0000887) | 1.67166438 |
| 160 | Hemoptysis (HP:0002105) | 1.66454661 |
| 161 | Abnormality of the tricuspid valve (HP:0001702) | 1.66000531 |
| 162 | Abnormality of monocarboxylic acid metabolism (HP:0010996) | 1.65758446 |
| 163 | Abnormality of glycolipid metabolism (HP:0010969) | 1.65688629 |
| 164 | Abnormality of liposaccharide metabolism (HP:0010968) | 1.65688629 |
| 165 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 1.65688629 |
| 166 | Autoimmune hemolytic anemia (HP:0001890) | 1.65482814 |
| 167 | Aortic aneurysm (HP:0004942) | 1.64880758 |
| 168 | Spastic paraparesis (HP:0002313) | 1.60643990 |
| 169 | Plantar hyperkeratosis (HP:0007556) | 1.60003660 |
| 170 | Congenital ichthyosiform erythroderma (HP:0007431) | 1.59904577 |
| 171 | Lethargy (HP:0001254) | 1.59804796 |
| 172 | Increased cerebral lipofuscin (HP:0011813) | 1.59674899 |
| 173 | Respiratory failure (HP:0002878) | 1.59181918 |
| 174 | 3-Methylglutaconic aciduria (HP:0003535) | 1.58987473 |
| 175 | Increased serum pyruvate (HP:0003542) | 1.58951818 |
| 176 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 1.58654563 |
| 177 | Irregular vertebral endplates (HP:0003301) | 1.58536700 |
| 178 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.57376229 |
| 179 | Amyloidosis (HP:0011034) | 1.57035038 |
| 180 | Absent thumb (HP:0009777) | 1.56718001 |
| 181 | Nuclear cataract (HP:0100018) | 1.56011022 |
| 182 | Aplasia/Hypoplasia involving the vertebral column (HP:0008518) | 1.55820347 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | BCKDK | 3.53041119 |
| 2 | SCYL2 | 3.27789784 |
| 3 | NME2 | 3.22860413 |
| 4 | IRAK3 | 3.20153068 |
| 5 | INSRR | 3.18995359 |
| 6 | MAP3K14 | 2.91023376 |
| 7 | ARAF | 2.90373675 |
| 8 | TXK | 2.68736883 |
| 9 | IRAK4 | 2.66387490 |
| 10 | CDC7 | 2.52065749 |
| 11 | MAP3K11 | 2.38622685 |
| 12 | TAOK3 | 2.37528043 |
| 13 | TGFBR2 | 2.27688409 |
| 14 | TESK1 | 2.20317396 |
| 15 | JAK1 | 2.16243308 |
| 16 | NUAK1 | 2.12301254 |
| 17 | JAK3 | 2.10448186 |
| 18 | TESK2 | 2.10284391 |
| 19 | IKBKE | 2.02870296 |
| 20 | TYK2 | 1.99543124 |
| 21 | ABL2 | 1.87340833 |
| 22 | FRK | 1.76787430 |
| 23 | EPHA3 | 1.73212530 |
| 24 | LATS1 | 1.70632349 |
| 25 | EIF2AK2 | 1.62094016 |
| 26 | STK16 | 1.59197568 |
| 27 | TEC | 1.58675884 |
| 28 | ZAK | 1.58016311 |
| 29 | NLK | 1.53932060 |
| 30 | KIT | 1.53856409 |
| 31 | ERN1 | 1.53590939 |
| 32 | IKBKB | 1.52003520 |
| 33 | SIK1 | 1.50824851 |
| 34 | EIF2AK1 | 1.49376637 |
| 35 | EPHA2 | 1.48501661 |
| 36 | FGFR3 | 1.48222352 |
| 37 | TNIK | 1.47949573 |
| 38 | PIK3CG | 1.47871015 |
| 39 | KDR | 1.46524430 |
| 40 | FGFR4 | 1.45533998 |
| 41 | MAP3K12 | 1.45320178 |
| 42 | CAMK1D | 1.44490946 |
| 43 | TRPM7 | 1.39732957 |
| 44 | ILK | 1.39114350 |
| 45 | CHUK | 1.37812098 |
| 46 | BRAF | 1.34731809 |
| 47 | MAP4K1 | 1.33545818 |
| 48 | MOS | 1.31687091 |
| 49 | EIF2AK3 | 1.29519339 |
| 50 | LRRK2 | 1.27437683 |
| 51 | GRK6 | 1.27381735 |
| 52 | RPS6KB2 | 1.25997039 |
| 53 | GRK7 | 1.21707000 |
| 54 | TBK1 | 1.21275647 |
| 55 | MYLK | 1.18072521 |
| 56 | TRIM28 | 1.17604362 |
| 57 | IRAK1 | 1.16695482 |
| 58 | BLK | 1.15506111 |
| 59 | CAMK1G | 1.10504210 |
| 60 | MATK | 1.10314196 |
| 61 | RIPK4 | 1.10242364 |
| 62 | FLT3 | 1.09894977 |
| 63 | ZAP70 | 1.07975005 |
| 64 | PLK4 | 1.06963923 |
| 65 | PIK3CA | 1.06543956 |
| 66 | NEK9 | 1.01998891 |
| 67 | CSK | 1.00110933 |
| 68 | NEK6 | 0.99421546 |
| 69 | EPHB2 | 0.99218559 |
| 70 | MAPK15 | 0.98190489 |
| 71 | TIE1 | 0.98112454 |
| 72 | NEK1 | 0.97095668 |
| 73 | HCK | 0.93274002 |
| 74 | TAOK2 | 0.93235883 |
| 75 | MST1R | 0.92830451 |
| 76 | PAK4 | 0.92567435 |
| 77 | AURKB | 0.92555504 |
| 78 | STK24 | 0.92543582 |
| 79 | BMPR2 | 0.91336768 |
| 80 | TTK | 0.90453065 |
| 81 | PDK2 | 0.88031337 |
| 82 | BTK | 0.87924619 |
| 83 | YES1 | 0.87600744 |
| 84 | LCK | 0.87073048 |
| 85 | VRK2 | 0.86427565 |
| 86 | DMPK | 0.85519477 |
| 87 | BRD4 | 0.84482084 |
| 88 | RAF1 | 0.84401659 |
| 89 | AURKA | 0.84131541 |
| 90 | MAP3K2 | 0.79912741 |
| 91 | PDGFRB | 0.79363411 |
| 92 | MAP3K1 | 0.79227533 |
| 93 | ITK | 0.77042033 |
| 94 | LYN | 0.76574962 |
| 95 | GRK1 | 0.75956998 |
| 96 | EPHB1 | 0.75931514 |
| 97 | PIM2 | 0.75866598 |
| 98 | CSF1R | 0.75638202 |
| 99 | PRKD2 | 0.75380874 |
| 100 | PRKAA2 | 0.75171902 |
| 101 | MAP2K3 | 0.75134948 |
| 102 | CDK7 | 0.75113543 |
| 103 | MAP2K2 | 0.74276330 |
| 104 | JAK2 | 0.71839052 |
| 105 | STK3 | 0.68869864 |
| 106 | MKNK2 | 0.68335074 |
| 107 | MAPK7 | 0.67089106 |
| 108 | PIM1 | 0.63447015 |
| 109 | DYRK1B | 0.63197093 |
| 110 | TNK2 | 0.62671538 |
| 111 | SYK | 0.62423289 |
| 112 | ATR | 0.61107596 |
| 113 | CHEK2 | 0.60903207 |
| 114 | SGK2 | 0.60449006 |
| 115 | HIPK2 | 0.60438927 |
| 116 | DAPK3 | 0.59828209 |
| 117 | IGF1R | 0.59574119 |
| 118 | MAP3K3 | 0.59278907 |
| 119 | CDK8 | 0.58442781 |
| 120 | PBK | 0.56893159 |
| 121 | ABL1 | 0.55639409 |
| 122 | CSNK2A1 | 0.55359557 |
| 123 | PLK1 | 0.55201502 |
| 124 | PRKCQ | 0.55079406 |
| 125 | PRKCI | 0.54858339 |
| 126 | MUSK | 0.54708047 |
| 127 | PTK6 | 0.54375509 |
| 128 | SMG1 | 0.53822261 |
| 129 | AKT2 | 0.52641598 |
| 130 | CHEK1 | 0.52582617 |
| 131 | MAP4K2 | 0.51746487 |
| 132 | MST4 | 0.51597886 |
| 133 | CSNK2A2 | 0.51230688 |
| 134 | CDK3 | 0.49942887 |
| 135 | SGK3 | 0.49713461 |
| 136 | FES | 0.49470973 |
| 137 | STK39 | 0.49452720 |
| 138 | STK10 | 0.49221453 |
| 139 | IRAK2 | 0.48936086 |
| 140 | AKT3 | 0.48721601 |
| 141 | MAP3K8 | 0.48485060 |
| 142 | BMX | 0.47253288 |
| 143 | CDK12 | 0.45934002 |
| 144 | PTK2 | 0.44907568 |
| 145 | ADRBK2 | 0.44103524 |
| 146 | STK4 | 0.41231838 |
| 147 | MAP3K7 | 0.41181252 |
| 148 | MAPKAPK3 | 0.41041710 |
| 149 | INSR | 0.40652048 |
| 150 | PRKCE | 0.40005227 |
| 151 | PKN1 | 0.39885296 |
| 152 | CDK9 | 0.39251041 |
| 153 | FGFR2 | 0.39054169 |
| 154 | CLK1 | 0.37449900 |
| 155 | MTOR | 0.37154902 |
| 156 | CDK6 | 0.33919198 |
| 157 | PAK1 | 0.33899694 |
| 158 | SRPK1 | 0.32890180 |
| 159 | LIMK1 | 0.32431708 |
| 160 | CASK | 0.31958633 |
| 161 | PDGFRA | 0.30359258 |
| 162 | CDK4 | 0.29948448 |
| 163 | MARK2 | 0.29910592 |
| 164 | RPS6KL1 | 0.29856731 |
| 165 | RPS6KC1 | 0.29856731 |
| 166 | GSK3A | 0.28781652 |
| 167 | MAP3K13 | 0.28719553 |
| 168 | RPS6KA4 | 0.28409904 |
| 169 | DYRK3 | 0.26916979 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Ribosome_Homo sapiens_hsa03010 | 3.67947713 |
| 2 | DNA replication_Homo sapiens_hsa03030 | 2.71938122 |
| 3 | Mismatch repair_Homo sapiens_hsa03430 | 2.53386797 |
| 4 | Sulfur relay system_Homo sapiens_hsa04122 | 2.48126038 |
| 5 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 2.47978966 |
| 6 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 2.34570530 |
| 7 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 2.34433878 |
| 8 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.23484008 |
| 9 | Leishmaniasis_Homo sapiens_hsa05140 | 2.18256834 |
| 10 | Homologous recombination_Homo sapiens_hsa03440 | 2.11432733 |
| 11 | Base excision repair_Homo sapiens_hsa03410 | 2.02181636 |
| 12 | Allograft rejection_Homo sapiens_hsa05330 | 2.01598755 |
| 13 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 1.96701443 |
| 14 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 1.94687770 |
| 15 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 1.92426483 |
| 16 | Drug metabolism - other enzymes_Homo sapiens_hsa00983 | 1.86450501 |
| 17 | Malaria_Homo sapiens_hsa05144 | 1.82517282 |
| 18 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.81830546 |
| 19 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79652553 |
| 20 | Proteasome_Homo sapiens_hsa03050 | 1.76605192 |
| 21 | Measles_Homo sapiens_hsa05162 | 1.76405293 |
| 22 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.74561434 |
| 23 | Nucleotide excision repair_Homo sapiens_hsa03420 | 1.73276320 |
| 24 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 1.70775611 |
| 25 | Osteoclast differentiation_Homo sapiens_hsa04380 | 1.69664383 |
| 26 | Caffeine metabolism_Homo sapiens_hsa00232 | 1.68918755 |
| 27 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.66845551 |
| 28 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.65661149 |
| 29 | Other glycan degradation_Homo sapiens_hsa00511 | 1.64219908 |
| 30 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.56774805 |
| 31 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.54314556 |
| 32 | Fanconi anemia pathway_Homo sapiens_hsa03460 | 1.52785528 |
| 33 | Folate biosynthesis_Homo sapiens_hsa00790 | 1.52771774 |
| 34 | Porphyrin and chlorophyll metabolism_Homo sapiens_hsa00860 | 1.51918446 |
| 35 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 1.50690434 |
| 36 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.50616058 |
| 37 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 1.49375511 |
| 38 | Pyrimidine metabolism_Homo sapiens_hsa00240 | 1.47292237 |
| 39 | Parkinsons disease_Homo sapiens_hsa05012 | 1.43595060 |
| 40 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 1.43393528 |
| 41 | Primary immunodeficiency_Homo sapiens_hsa05340 | 1.42250552 |
| 42 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.40841715 |
| 43 | * Protein processing in endoplasmic reticulum_Homo sapiens_hsa04141 | 1.37253027 |
| 44 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.37169369 |
| 45 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 1.36113589 |
| 46 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 1.32621493 |
| 47 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.29435513 |
| 48 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 1.28711157 |
| 49 | Galactose metabolism_Homo sapiens_hsa00052 | 1.27783008 |
| 50 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 1.26739979 |
| 51 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.22600646 |
| 52 | Pertussis_Homo sapiens_hsa05133 | 1.22088408 |
| 53 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 1.21874884 |
| 54 | Lysine degradation_Homo sapiens_hsa00310 | 1.21012606 |
| 55 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 1.18917474 |
| 56 | ABC transporters_Homo sapiens_hsa02010 | 1.17871091 |
| 57 | Asthma_Homo sapiens_hsa05310 | 1.17489759 |
| 58 | Huntingtons disease_Homo sapiens_hsa05016 | 1.17365918 |
| 59 | Influenza A_Homo sapiens_hsa05164 | 1.14843206 |
| 60 | Herpes simplex infection_Homo sapiens_hsa05168 | 1.14033300 |
| 61 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.14015918 |
| 62 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.12665343 |
| 63 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 1.11263336 |
| 64 | Protein export_Homo sapiens_hsa03060 | 1.08409608 |
| 65 | Steroid hormone biosynthesis_Homo sapiens_hsa00140 | 1.07396492 |
| 66 | Tuberculosis_Homo sapiens_hsa05152 | 1.07363873 |
| 67 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.07292716 |
| 68 | Lysosome_Homo sapiens_hsa04142 | 1.05794719 |
| 69 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.03604200 |
| 70 | Legionellosis_Homo sapiens_hsa05134 | 1.03266929 |
| 71 | Transcriptional misregulation in cancer_Homo sapiens_hsa05202 | 0.97232454 |
| 72 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.96644063 |
| 73 | Vitamin digestion and absorption_Homo sapiens_hsa04977 | 0.96530997 |
| 74 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.95743236 |
| 75 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.95033671 |
| 76 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.94418925 |
| 77 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.92768868 |
| 78 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.91863482 |
| 79 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.90769538 |
| 80 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 0.90606519 |
| 81 | Carbon metabolism_Homo sapiens_hsa01200 | 0.90431800 |
| 82 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 0.90303103 |
| 83 | Hepatitis C_Homo sapiens_hsa05160 | 0.86008810 |
| 84 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.84991558 |
| 85 | Alzheimers disease_Homo sapiens_hsa05010 | 0.84540156 |
| 86 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.83964279 |
| 87 | Bladder cancer_Homo sapiens_hsa05219 | 0.82494224 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.81782314 |
| 89 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 0.81754637 |
| 90 | RNA polymerase_Homo sapiens_hsa03020 | 0.81625323 |
| 91 | Metabolic pathways_Homo sapiens_hsa01100 | 0.80997075 |
| 92 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.80010431 |
| 93 | Ribosome biogenesis in eukaryotes_Homo sapiens_hsa03008 | 0.79878322 |
| 94 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.79353938 |
| 95 | T cell receptor signaling pathway_Homo sapiens_hsa04660 | 0.78804294 |
| 96 | Spliceosome_Homo sapiens_hsa03040 | 0.77079393 |
| 97 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.75939071 |
| 98 | One carbon pool by folate_Homo sapiens_hsa00670 | 0.75413202 |
| 99 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.73947404 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.73902127 |
| 101 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 0.72911695 |
| 102 | Histidine metabolism_Homo sapiens_hsa00340 | 0.72815731 |
| 103 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 0.72814407 |
| 104 | Hepatitis B_Homo sapiens_hsa05161 | 0.72076457 |
| 105 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.72069144 |
| 106 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 0.71856925 |
| 107 | p53 signaling pathway_Homo sapiens_hsa04115 | 0.71391251 |
| 108 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.70481409 |
| 109 | Platelet activation_Homo sapiens_hsa04611 | 0.70063257 |
| 110 | Salmonella infection_Homo sapiens_hsa05132 | 0.69746567 |
| 111 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.68189160 |
| 112 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.67436778 |
| 113 | Apoptosis_Homo sapiens_hsa04210 | 0.66384206 |
| 114 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.64924853 |
| 115 | Amoebiasis_Homo sapiens_hsa05146 | 0.64058315 |
| 116 | Retinol metabolism_Homo sapiens_hsa00830 | 0.61269509 |
| 117 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.59578590 |
| 118 | Drug metabolism - cytochrome P450_Homo sapiens_hsa00982 | 0.59212786 |
| 119 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.58242781 |
| 120 | Prostate cancer_Homo sapiens_hsa05215 | 0.57535093 |
| 121 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.57171972 |
| 122 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.56334265 |
| 123 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.56219360 |
| 124 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 0.56113364 |
| 125 | Peroxisome_Homo sapiens_hsa04146 | 0.56036162 |
| 126 | RNA transport_Homo sapiens_hsa03013 | 0.55498423 |
| 127 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.55425169 |
| 128 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.55249333 |
| 129 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.54999574 |
| 130 | Viral myocarditis_Homo sapiens_hsa05416 | 0.54810979 |
| 131 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.54510883 |
| 132 | Circadian rhythm_Homo sapiens_hsa04710 | 0.53495256 |
| 133 | Focal adhesion_Homo sapiens_hsa04510 | 0.52978581 |
| 134 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.52660995 |
| 135 | Chemical carcinogenesis_Homo sapiens_hsa05204 | 0.52464542 |
| 136 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.51610231 |
| 137 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.49440320 |
| 138 | Insulin resistance_Homo sapiens_hsa04931 | 0.48723379 |
| 139 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.48700321 |
| 140 | Adherens junction_Homo sapiens_hsa04520 | 0.47450599 |
| 141 | Phagosome_Homo sapiens_hsa04145 | 0.46181300 |
| 142 | Shigellosis_Homo sapiens_hsa05131 | 0.45468984 |
| 143 | Non-homologous end-joining_Homo sapiens_hsa03450 | 0.45446653 |
| 144 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.45347139 |
| 145 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.44383817 |
| 146 | Basal transcription factors_Homo sapiens_hsa03022 | 0.44279160 |
| 147 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.44137644 |
| 148 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.43756652 |
| 149 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.43535837 |
| 150 | Metabolism of xenobiotics by cytochrome P450_Homo sapiens_hsa00980 | 0.42224754 |
| 151 | Renin-angiotensin system_Homo sapiens_hsa04614 | 0.41699573 |
| 152 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.41364959 |
| 153 | Systemic lupus erythematosus_Homo sapiens_hsa05322 | 0.41205953 |
| 154 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.39734794 |
| 155 | Arachidonic acid metabolism_Homo sapiens_hsa00590 | 0.39180252 |
| 156 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.38972643 |
| 157 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.37993776 |
| 158 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.36609206 |
| 159 | RNA degradation_Homo sapiens_hsa03018 | 0.34941957 |
| 160 | Purine metabolism_Homo sapiens_hsa00230 | 0.34266538 |
| 161 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.34161369 |
| 162 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 0.34128840 |

